Forward Pharma A/S logo
Forward Pharma A/S FWP

Annual report 2021
added 12-23-2023

report update icon

Forward Pharma A/S Gross Profit 2011-2026 | FWP

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Forward Pharma A/S

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 1.22 B - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.22 B 1.22 B 1.22 B

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
Advaxis Advaxis
ADXS
90 K - -9.65 % $ 45.9 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-104 K $ 0.79 0.04 % $ 4.31 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
9.54 M $ 6.45 -2.71 % $ 177 M israelIsrael
Adverum Biotechnologies Adverum Biotechnologies
ADVM
2.32 M - - $ 86.2 M usaUSA
argenx SE argenx SE
ARGX
2.68 M $ 708.53 0.74 % $ 25 B niderlandNiderland
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
177 K $ 3.43 -4.99 % $ 8.25 B australiaAustralia
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
625 M $ 229.59 -0.62 % $ 5 B danmarkDanmark
BioCardia BioCardia
BCDA
141 K $ 1.3 2.36 % $ 27.5 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
Athersys Athersys
ATHX
1.44 M - 3.77 % $ 22.4 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
1.27 M - 2.71 % $ 14 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M $ 3.49 -2.51 % $ 7.59 B israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
109 M $ 11.08 -4.32 % $ 990 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
4.73 M - 5.93 % $ 314 M canadaCanada
Anika Therapeutics Anika Therapeutics
ANIK
103 M $ 14.49 0.91 % $ 212 M usaUSA
Aptinyx Aptinyx
APTX
1.56 K - -39.0 % $ 4.57 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
4.77 M - - $ 521 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
45.8 M $ 2.6 -1.52 % $ 16.3 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-10.6 M - - $ 867 M germanyGermany
Aravive Aravive
ARAV
5.68 K - -13.39 % $ 1.45 M usaUSA